Fastin® brings forth a trifecta of advancements in the fat loss arena: 1) a sophisticated manufacturing process that utilizes a dual delivery system technology for specific control of rapid and sustained release of its active compounds, 2) a proprietary active compound formulation that trumps the existing field of tat loss compounds and puts even ephedra in the back seat, 3) a novel approach to fat loss through triggering fat cell death (apoptosis).
Hi-Tech Pharmaceuticals recently launched Fastin® into the weight loss arena. In recent months. Hi-Tech acquired rights to Fastin from King Pharmaceuticals. King Pharmaceuticals manufactured the brand name product Fastin (phentermine FICL) for Smith Kline Beecham. In December 1998, SK-Beecham withdrew Fastin from the market. Hi-Tech Pharmaceuticals has reformulated Fastin® and expects it to be their top weight loss aid. Fastin® is a pharmaceutical-grade dietary supplement indicated for weight loss in extremely overweight individuals. Fastin® has both immediate and delayed release profiles for appetite suppression, energy, and weight loss. Fastin® is comprised of nine pharmaceutical-grade fat loss catalysts at precise ratios in order to achieve its extraordinary results.